HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/2/2024ACC: 0001209191-24-000070
Officer· SVP, Chief Accounting Officer
Since Mar 2026
+1K
Net shares
Net buyer
$63.0K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
4K acquired · 3K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1K
Price / share
—
Trade value
—
% of position
4.2%
12/20/2023
23.61K→24.61K
Common Stock
Direct
Shares
+3K
Price / share
$21.00
Trade value
$63K
% of position
12.1%
1/2/2024
24.89K→27.89K
Total
Net shares
+4K
Net value
$63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2023 | A · Award | +1K | — | — | 4.2% | 23.61K | 24.61K |
| Common Stock Direct | 1/2/2024 | M · Option Exercise | +3K | $21.00 | $63K | 12.1% | 24.89K | 27.89K |
| Total | +4K | $63K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3K shares
Shares
−3K
Strike price
21.00
Held after
0.00
Exercisable
—
1/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3K shares | 1/2/2024 | M · Option Exercise | −3K | 21.00 | — | 0.00 |